Spitalul Clinic de Psihiatrie “Dr. Gheorghe Preda” Sibiu

Verified siteinfo

Romania Strada Doctor Dumitru Bagdazar Nr 12, 550082 Sibiu, Romania

6 trials recruiting
Dementia Alzheimer's type · Major depression · Schizophrenia
Adults and children

About Specializations

Spitalul Clinic de Psihiatrie “Dr. Gheorghe Preda” Sibiu in Sibiu, Romania specialises in clinical trials of conditions such as Dementia Alzheimer's type, Major depression, Schizophrenia, Anhedonia, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology

The medical center is at the forefront of neurology research, with a particular focus on pediatric conditions. The ongoing studies aim to enhance the understanding and treatment of neurological disorders in children and adolescents.

Episodic Migraine in Pediatric Patients

Through innovative research, the center is dedicated to improving the quality of life for young patients suffering from episodic migraine, exploring new therapeutic options to manage and alleviate symptoms effectively.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Strada Doctor Dumitru Bagdazar Nr 12550082 SibiuRomania

Open in maps ↗

Recruiting now: 6 trials
Conditions studied: 7
Partner status: Verified site

More sites in Sibiu Romania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

7 clinical trials

Dementia Alzheimer's type

Recruiting

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

InvestigationalNo placebo

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

InvestigationalNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Trospium Chloride
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Schizophrenia

Recruiting

Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

Investigational

Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

Investigational

Romania

Participants:18–64 years
Substances:Vafidemstat
Sponsor:Oryzon Genomics S.A.

Contact Research Centre

Schizophrenia

Recruiting

A Study Testing Brexpiprazole Given Once Weekly to Treat Sudden Worsening of Symptoms in Patients with Schizophrenia

Registered drug

A Study Testing Brexpiprazole Given Once Weekly to Treat Sudden Worsening of Symptoms in Patients with Schizophrenia

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Brexpiprazole
Sponsor:Otsuka Pharmaceutical Co. Ltd.

Contact Research Centre

Major depression

Recruiting

A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

Registered drug